AI assistant
Sending…
HAEMONETICS CORP — Director's Dealing 2019
May 1, 2019
31565_dirs_2019-05-01_ff9968a4-ef33-44f9-90ff-f3e1d68061b8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2019-04-24
Reporting Person: Pomeroy Claire (Director)
More from HAEMONETICS CORP
Major Shareholding Notification
2026
May 13
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 1
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Major Shareholding Notification
2026
Mar 27
Major Shareholding Notification
2026
Mar 4
Regulatory Filings
2026
Mar 3
Major Shareholding Notification
2026
Feb 13
Regulatory Filings
2026
Feb 12